GENTAUR Contact Gentaur

Up

GENTAUR Survey

GENTAUR EUROPE

+32 1658 9045
+32 1650 9045

BELGIUM1

tel +32 2 732 5688
fax +32 2 732 4414
info@gentaur.com
Av. de l' Armée 68
B-1040 Brussels

France

tel 01 43 25 01 50
fax 01 43 25 01 60
9, rue Lagrange
75005 Paris

Italy

tel 02 36 00 65 93
fax +32 16 50 90 45
20135 Milano

Germany

tel +32 16 58 90 45
fax +32 16 50 90 45
Forckenbeckstraße 6
D-52074 Aachen

Japan

tel +81 78 386 0860
fax +81 78 306 0296
Minaatojimaminami-manchi
Chuo-ku, Kobe
065-0047


, (2003)'Activation of VEGF-R1 sustains angiogenesis and Bcl-2 expression via the PI3-kinase pathway in endothelial cells' Diabetes 52; 2951-2968 

9.      Duval, H. et al, (2003)'New insights into the function and regulation of endothelial cell apoptosis' Angiogenesis  6; 171-183 

10.   Shalhoub, J. et al, 2003 'Anti-angiogenic activity of heparins and anti-thrombin' J. Thromb. Haemostasis 1; Suppl 1 Abstract  P0846 

11.  Numasaki, M. et al, (2003) 'Interleukin-17 promotes angiogenesis and tumour growth' Blood 101; 2620-2627 

12.  Burns, P.A. & Wilson, D.J., (2003) 'Angiogenesis mediated by metabolites is dependent on VEGF' Angiogenesis 6; 23-77

13.  Shalhoub, J. et al, (2003) 'Anti-angiogenic activity of heparins and antithrombin J. Thromb. Haemostasis 1 Suppl July, P0846 

14.  Sengupta, S. et al (2003) 'Thymidine phosphorylase induces angiogenesis in vivo and in vitro: an evaluation of possible mechanisms' Brit. J. Pharmacol. 139; 219-231 

15.  Oshima, Y. et al, (2003) 'Expression and localisation of tenomodulin, a transmembrane type chondomodulin-I-related angiogenesis inhibitor, in mouse eyes'. Invest. Ophthalmol. Vis. Sci. 44; 1814-1823

 16.  Igagarishi, T. et al (2003) 'Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularisation in a murine proliferative retinopathy model'. Gene Therapy 10; 219-226 

17.  Rossig, L., et al, (2002) "Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation & angiogenesis" Circulation Research 91, 837-851 

18.  Gliki, G. et al, (2002) ‘Vascular endothelial growth factor induces protein kinase c (PKC)-dependent Akt/PKB activation and phosphatidylinositol 3’-kinase-mediated PKCd phosphorylation: Role of PKC in angiogenesis’ Cell Biology International 26; 751-759  

19.  Brooks, T. et al,  Proc. AACR 43; 137 (2002) 

20.  Drinkwater, S.L., et al, (2002)  ‘Effect of venous ulcer exudates on angiogenesis in vitro’ Brit. J. Surg. 89; 709-713 

21.  Urbich, C. et al. (2002) 'Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogeneic effects of endostatin'. FASEB J. express article 10.1096/fj.01-0637fje. 

22.  Urbich, C. et al. (2002) 'Double-Edged Role of Statins in Angiogenesis Signalling' Circulation Research. 90: 737-744. 

23.  Osugi, T. et al (2002) 'Cardiac-specific activation of Signal Transducer and Activator of Transcription-3 promotes vascular formation in the heart'J. Biol. Chem. 227; 6676-6681 

24.  Kronenwett, R. et al, (2002) 'Inhibition of angiogenesis in vitro by aV integrin-directed antisense oligonucleotides'.Cancer Gene Therapy 9; 587-596 

25.  Dredge, K. et al (2002) 'Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects'. Brit. J. Cancer 87; 1166-1172 

26.   Urbich et al (2002) 'CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species' Circulation, 106; 981-986 

27.  Svensson, L.A. et al (2002) 'The cytolethal distending toxin of Haemophilus ducreyi inhibits endothelial cell proliferation' Infection & Immunity 70; 2665-2669 

28.   Iba, O. et al, (2002) "Angiogenesis by implantation of peripheral blood mononuclear cells into ischaemic limbs" Circulation 106: 2019 

29.  Harmey, J.H. et al, (2002)'Lipoylsaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumour invasion' Int. J. Cancer 101; 415-422  

30.  Terai, Y. et al, (2001) 'Vascular smooth muscle cell growth promoting factor / F-spondin inhibits angiogenesis via the blockade of integrin aVb3 on vascular endothelial cells. J. Cell. Physiol. 188; 394-402 

31.  Ohno-Matsui, K. et al, (2001) 'Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF' J. Cell. Physiol. 189; 323-333 

32.  Jia, H. et al, (2001) ‘Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF’Biochem. Biophys. Res. Commun. 283; 164-173 

33.  Murphy, J.E. & Fitzgerald, D.J., (2001) ‘Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor’. FASEB J. 15; 1667-1 

34.   Houston, P. et al, (2001) ‘The transcriptional co-repressor NAB2 blocks Egr-1-mediated growth factor activation and angiogenesis’ Biochem. Biophys. Res. Commun. 283; 480-486  

35.  Bussolati, B. et al, (2001) ‘Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide’ Am. J. Path. 159; 993-1008  

36.  Frandsen, T. et al,  Clin. Cancer Res. 7; Suppl. (2001) 

37.  Donovan et al, (2001)  ‘Comparison of three in vitro human ‘angiogenesis’ assays with capillaries formed in vivo’ Angiogenesis 4; 113-121  

38.  Bryant,  et al , (2000)‘Tissue repair with a therapeutic transcription factor’

Human Gene Therapy 11; 2143-2158  

39.   Bishop, E.T. et al, (2000) ‘An in vitro model of angiogenesis: Basic features Angiogenesis 3; (4); 335-344 

40.  Brooks, T.D. et al, (1999) ‘Antibodies to PAI-1 suppress angiogenesis in vitro’Clin. Exp. Metastasis 17 (9); 112  

41.  Grohmann, M et al, (1999)‘Nitric oxide released via VEGFR-1 suppresses VEGFR-2 mediated endothelial cell growth and regulates angiogenesis’J. Reprod. Fertil. (Abs Series 24) No 48

TCS AngioKit:  CD31 stained tubule formation


 

 

 

Home Up

send mail to webmaster@gentaur.com with questions or comments about this web site.
Copyright © 2008 Gentaur Molecular Products
Site powered by Acid Dragon (AC)
Last modified: 05/19/16